Melanotan I
Typical Dosage
50-200 mcg
Administration
Injection
Half-Life
~30 minutes
Mechanism of Action
Photoprotection research|Melanogenesis studies|EPP-related therapy|UV-resistance models
Research Protocol Summary
Evidence Level
Early Human / Investigational
Typical Protocol Duration
4-6 weeks
Species Studied
Human • Mouse
Administration Schedule
Daily/Maintenance Weekly
Timing Notes
Week 1: 50-200 mcg daily; Maintnenace 100 mcg 2 times a week
Studies
Research Availability
Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.
Related resources
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Loading approved insights…